ISSN: 1300-7777 E-ISSN: 1308-5263
Hodgkin’s Disease: Results of a Single Center in Central Anatolia [Turk J Hematol]
Turk J Hematol. 2001; 18(2): 117-122

Hodgkin’s Disease: Results of a Single Center in Central Anatolia

H. Şenol Coşkun1, Bülent Eser2, Mustafa Çetin2, Özlem Er1, Ali Ünal2, Mustafa Altınbaş1, Eray Karahacıoğlu3, Bünyamin Kaplan3
1Department Of Medical Oncology, Erciyes University Medical Faculty
2Department Of Haematology, Erciyes University Medical Faculty
3Department Of Radiation Oncology, Erciyes University Medical Faculty, Kayseri, Turkey

Hodgkin’s Disease (HD) accounts for about 1% of newly diagnosed malignant diseases. In this study 119 HD cases followed in Erciyes University Hospital were evaluated. 67.2% of the patients was male, 32.8% female. The patients’ age ranged from 15 to 72 years with a median of 41.5 years. Of the patients 10.1% was stage I, 29.4% stage II, 39.5% stage III, and 21.0% stage IV. According to Rye classification frequency of histologic
subtypes was as follows; 21.0% lymphocyte predominant, 25.2% nodular sclerosis, 43.7% mixed cellularity, and 10.1% lymphocyte depletion. Combination chemotherapy consisting cyclophosphamide, vincristine, procarbazine and prednisolone (COPP) was used as first line treatment in 59.7% of patients. Complete remission was achieved in 84.9% of patients and partial remission in 5.0% of patients; response could not be obtained in remaining 10.1% of patients. Disease progression or recurrence was observed in 30.2% of patients. Five year survival rate was found as 70.8% of all patients, 90.1% for stage I-II, 55.3% for stage III-IV patients (p= 0.03).

Keywords: Hodgkin's Disease, Clinical features, Survival, Adult.


H. Şenol Coşkun, Bülent Eser, Mustafa Çetin, Özlem Er, Ali Ünal, Mustafa Altınbaş, Eray Karahacıoğlu, Bünyamin Kaplan. Hodgkin’s Disease: Results of a Single Center in Central Anatolia. Turk J Hematol. 2001; 18(2): 117-122

Corresponding Author: H. Şenol Coşkun, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686